Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Other Operating Expenses: 2021-2024

Historic Other Operating Expenses for Cidara Therapeutics (CDTX) over the last 2 years, with Dec 2024 value amounting to $84.9 million.

  • Cidara Therapeutics' Other Operating Expenses was N/A to $45.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.4 million, marking a year-over-year change of. This contributed to the annual value of $84.9 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Cidara Therapeutics' Other Operating Expenses is $84.9 million, which was up 196.32% from -$88.1 million recorded in FY2021.
  • Over the past 5 years, Cidara Therapeutics' Other Operating Expenses peaked at $84.9 million during FY2024, and registered a low of -$88.1 million during FY2021.
  • For the 1-year period, Cidara Therapeutics' Other Operating Expenses averaged around $84.9 million, with its median value being $84.9 million (2024).